4th International Ayurved Cardiology Symposium Sees Participation Of 200 Ayurveda Practitioners From Across World

Founder and CEO Dr Rohit Sane facilitated 49 Ayurveda practitioners for practicing evidence-based treatment in the field of chronic cardiac and metabolic disorders.

Founder and CEO Dr Rohit Sane facilitated 49 Ayurveda practitioners for practicing evidence-based treatment in the field of chronic cardiac and metabolic disorders.
Founder and CEO Dr Rohit Sane facilitated 49 Ayurveda practitioners for practicing evidence-based treatment in the field of chronic cardiac and metabolic disorders.

Madhavbaug, the brand of Vaidya Sane Ayurved Laboratories Ltd, recently organised the 4th International Ayurved Cardiology Symposium at Baku, Azerbaijan. The event witnessed the participation of around 200 Ayurveda practitioners from around the world. Through this event, Madhavbaug is taking its treatment and reversal of chronic cardiac-related ailments through its scientific evidence-based Ayurveda therapies to abroad.

Founder and CEO Dr Rohit Sane facilitated 49 Ayurveda practitioners for practicing evidence-based treatment in the field of chronic cardiac and metabolic disorders. During the two-day event, he also released a souvenir of evidence-based research papers on the same subject.

“The Indian Ayurveda is one of the oldest indigenous systems of medicine and practice to heal the whole body and mind. While Ayurveda has survived through the ages, the true potential of our traditional system of treatment is yet to get unlocked. We strongly believe that our scientific evidence-based Ayurveda is going to change the way people approach Ayurveda. In coming years, we are confident of putting Indian Ayurveda on top of the global map,” said Dr Rohit Sane, MBBS and fellowship in preventive cardiology.

Madhavbaug also presented 49 research papers on various chronic cardiac ailments and case studies supported by clinical data about ayurvedic management of those cardiometabolic disorders. Some of the topic covered during the course of the event includes heart failure with preserved LVEF, congestive cardiac failure, chronic ischemic heart disease, high cholesterol, hypertension, Post MI management, management of DM retinopathy and management of diabetic wound with Ayurveda treatment principles.

It is important to mention that Madhavbaug, under Dr Sane’s leadership, has so far published over 150 research reports in peer-reviewed allopathic medical journals – nationally and globally highlighting its success in treating and reversing lifestyle disorders like diabetes, cardiovascular disease, hypertension and obesity.

Earlier this month, Madhavbaug organised a four-day National Ayurved Cardiology Symposium – the first of its kind in India to promote scientific evidence-based Ayurveda. The event brought together over 5,000 doctors from across India including practitioners of modern medicines.

Facebook Comments